Asche Chiesi and Janssen-Cilag to co-market asthma drugs

German firms Asche Chiesi GmbH, part of Italy's Chiesi group, and Janssen-Cilag GmbH, a unit of US health care major Johnson & Johnson, have established an agreement, under which they will share responsibility for marketing two asthma drugs that combine formoterol fumarate and beclometasone dipropionate. Under the terms of the deal, Janssen assumes rights to Inuvair, previously distributed by the German unit of Belgium's UCB, while Asche Chiesi will continue to market its product under the brand name Foster. Financial terms of the co-marketing agreement were not made public.